Login to Your Account



NewCo News

'Best of Unigene' Lands in Hands of Start-up Enteris

By Jennifer Boggs
Managing Editor

Monday, August 19, 2013
Crushing debt forced Unigene Laboratories Inc. into bankruptcy earlier this year, but its promising Peptelligence delivery technology has found a new home in start-up Enteris Biopharma Inc., which launched recently to develop oral formulations of both peptide drugs and currently injectable-only small molecules.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription